Burkholderiaceae

Burkholderiaceae is a family of bacteria within the order Pseudomonadales, class Gammaproteobacteria. This family includes a diverse group of organisms, many of which are significant from both an environmental and clinical perspective. Members of the Burkholderiaceae family are Gram-negative, rod-shaped bacteria that are found in various habitats, including soil, water, and the rhizosphere of plants. Some species within this family are known for their ability to degrade environmental pollutants, while others are notable pathogens of plants, animals, and humans.
Characteristics[edit]
Members of the Burkholderiaceae family are characterized by their Gram-negative cell wall structure, which includes a thin peptidoglycan layer sandwiched between an inner cytoplasmic membrane and an outer membrane. These bacteria are typically aerobic, although some species can grow under anaerobic conditions if alternative electron acceptors are available. They are metabolically diverse, capable of utilizing a wide range of organic compounds as energy and carbon sources.
Genus and Species[edit]
The Burkholderiaceae family comprises several genera, with Burkholderia and Ralstonia being among the most well-known. Burkholderia includes species such as Burkholderia cepacia, which is known for its role in causing infections in cystic fibrosis patients, and Burkholderia pseudomallei, the causative agent of melioidosis. Ralstonia, on the other hand, includes species like Ralstonia solanacearum, a plant pathogen responsible for causing wilt diseases in a variety of crops.
Ecological and Clinical Importance[edit]
The ecological importance of Burkholderiaceae lies in their ability to degrade various pollutants, such as hydrocarbons and pesticides, making them valuable for bioremediation efforts. Additionally, their presence in the rhizosphere can promote plant growth by fixing nitrogen, solubilizing phosphorus, and producing plant growth-promoting compounds.
Clinically, some members of the Burkholderiaceae family are significant pathogens. Burkholderia cepacia complex (BCC) is a group of closely related species that can cause serious respiratory infections in individuals with cystic fibrosis or chronic granulomatous disease. Burkholderia pseudomallei is another medically important species, responsible for melioidosis, a disease that can range from chronic infection to acute sepsis and is often fatal if not treated promptly.
Research and Treatment[edit]
Research on Burkholderiaceae focuses on understanding their pathogenesis, resistance mechanisms, and potential uses in bioremediation and agriculture. Treatment of infections caused by pathogenic Burkholderiaceae can be challenging due to their intrinsic resistance to many antibiotics. Therefore, accurate identification and susceptibility testing are crucial for effective treatment.
Conclusion[edit]
The Burkholderiaceae family encompasses a wide range of bacteria with significant ecological and clinical impacts. Their ability to degrade pollutants and promote plant growth highlights their potential in environmental management and agriculture. However, the pathogenic members of this family pose serious health risks, necessitating ongoing research and careful management of infections.
|
This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia. |
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian